HK1067155A1 - Stem cells of the islets of langerhans and their use in treating diabetes mellitus - Google Patents

Stem cells of the islets of langerhans and their use in treating diabetes mellitus

Info

Publication number
HK1067155A1
HK1067155A1 HK05100504.4A HK05100504A HK1067155A1 HK 1067155 A1 HK1067155 A1 HK 1067155A1 HK 05100504 A HK05100504 A HK 05100504A HK 1067155 A1 HK1067155 A1 HK 1067155A1
Authority
HK
Hong Kong
Prior art keywords
stem cells
cells
pancreatic
methods
islet
Prior art date
Application number
HK05100504.4A
Other languages
English (en)
Inventor
Joel F Habener
Henryk Zulewski
Melissa K Thomas
Elizabeth J Abraham
Mario Vallejo
Colin A Leech
Anna Louise Nolan
Andreas Lechner
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/963,875 external-priority patent/US20020164307A1/en
Priority claimed from US10/136,891 external-priority patent/US6923959B2/en
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of HK1067155A1 publication Critical patent/HK1067155A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C12N5/0678—Stem cells; Progenitor cells; Precursor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/335—Glucagon; Glucagon-like peptide [GLP]; Exendin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Environmental Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Prostheses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK05100504.4A 2001-09-26 2005-01-19 Stem cells of the islets of langerhans and their use in treating diabetes mellitus HK1067155A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/963,875 US20020164307A1 (en) 1999-12-06 2001-09-26 Stem cells of the islets of langerhans and their use in treating diabetes mellitus
US10/120,687 US20030082155A1 (en) 1999-12-06 2002-04-11 Stem cells of the islets of langerhans and their use in treating diabetes mellitus
US10/136,891 US6923959B2 (en) 1999-12-06 2002-05-02 Method of pre-inducing a state of immune tolerance before organ transplantation
PCT/US2002/030700 WO2003026584A2 (en) 2001-09-26 2002-09-26 Stem cells of the islets of langerhans and their use in treating diabetes mellitus

Publications (1)

Publication Number Publication Date
HK1067155A1 true HK1067155A1 (en) 2005-04-01

Family

ID=38596629

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05100504.4A HK1067155A1 (en) 2001-09-26 2005-01-19 Stem cells of the islets of langerhans and their use in treating diabetes mellitus

Country Status (11)

Country Link
US (2) US20030082155A1 (ja)
EP (1) EP1438418B1 (ja)
JP (1) JP2005533746A (ja)
CN (1) CN1589330A (ja)
AT (1) ATE489475T1 (ja)
AU (1) AU2002331910B2 (ja)
CA (1) CA2461861A1 (ja)
DE (1) DE60238431D1 (ja)
HK (1) HK1067155A1 (ja)
IL (1) IL161119A0 (ja)
WO (1) WO2003026584A2 (ja)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4136434B2 (ja) * 2002-04-17 2008-08-20 進 清野 インスリン産生細胞の誘導
US7527968B2 (en) * 2002-07-29 2009-05-05 Robarts Research Institute Regeneration initiating cells
WO2004106921A2 (en) * 2003-05-27 2004-12-09 Mcgill University In vitro platform for screening agents inducing islet cell neogenesis
US8491883B2 (en) * 2003-06-27 2013-07-23 Advanced Technologies And Regenerative Medicine, Llc Treatment of amyotrophic lateral sclerosis using umbilical derived cells
US8518390B2 (en) 2003-06-27 2013-08-27 Advanced Technologies And Regenerative Medicine, Llc Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells
US8790637B2 (en) * 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
US9572840B2 (en) 2003-06-27 2017-02-21 DePuy Synthes Products, Inc. Regeneration and repair of neural tissue using postpartum-derived cells
US7875272B2 (en) * 2003-06-27 2011-01-25 Ethicon, Incorporated Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
US9592258B2 (en) 2003-06-27 2017-03-14 DePuy Synthes Products, Inc. Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
PL1641914T3 (pl) 2003-06-27 2017-01-31 DePuy Synthes Products, Inc. Komórki pochodzące z poporodowej tkanki łożyska oraz sposoby uzyskiwania i zastosowania tych komórek
US7237119B2 (en) * 2003-06-30 2007-06-26 At&T Intellectual Property, Inc. Method, system and computer program for managing user authorization levels
US7332336B2 (en) * 2003-08-19 2008-02-19 Effector Cell Institute, Inc. Methods for inducing differentiation of pluripotent cells
US20060205072A1 (en) * 2003-08-27 2006-09-14 Nobuko Uchida Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
WO2005071066A1 (en) * 2004-01-23 2005-08-04 Board Of Regents, The University Of Texas System Methods and compositions for preparing pancreatic insulin secreting cells
US8741635B2 (en) * 2004-05-12 2014-06-03 The Walter And Eliza Hall Institute Of Medical Research Method of cell isolation
WO2006001471A1 (ja) * 2004-06-29 2006-01-05 The University Of Tokyo グルコース応答性インスリン分泌を促進するための医薬組成物
US8017395B2 (en) 2004-12-17 2011-09-13 Lifescan, Inc. Seeding cells on porous supports
WO2006083394A2 (en) * 2004-12-21 2006-08-10 Ethicon, Inc. Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same
US20060171930A1 (en) * 2004-12-21 2006-08-03 Agnieszka Seyda Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same
US20060153815A1 (en) * 2004-12-21 2006-07-13 Agnieszka Seyda Tissue engineering devices for the repair and regeneration of tissue
PL1835924T3 (pl) 2004-12-23 2014-01-31 Ethicon Incorporated Leczenie choroby Parkinsona i zaburzeń związanych z tą chorobą z użyciem komórek uzyskiwanych po porodzie
ES2621847T3 (es) 2004-12-23 2017-07-05 DePuy Synthes Products, Inc. Células posparto derivadas de tejido de cordón umbilical, y métodos de elaboración y uso de las mismas
EP1676574A3 (en) 2004-12-30 2006-07-26 Johnson & Johnson Vision Care, Inc. Methods for promoting survival of transplanted tissues and cells
WO2006074308A2 (en) * 2005-01-07 2006-07-13 Wake Forest University Health Sciences Regeneration of pancreatic islets by amniotic fluid stem cell therapy
CA2512667A1 (en) * 2005-01-07 2006-07-07 Takahiro Ochiya Human hepatocyte-like cells and uses thereof
ES2627419T3 (es) * 2005-03-04 2017-07-28 Lifescan, Inc. Células estromales adultas derivadas del páncreas
AU2006202209B2 (en) 2005-05-27 2011-04-14 Lifescan, Inc. Amniotic fluid derived cells
US9074189B2 (en) * 2005-06-08 2015-07-07 Janssen Biotech, Inc. Cellular therapy for ocular degeneration
TW200716159A (en) * 2005-06-09 2007-05-01 Univ Maryland Method of use of antagonists of zonulin to prevent the loss of or to regenerate pancreatic cells
CN1982440B (zh) * 2005-07-15 2010-11-17 广西南宁灵康赛诺科生物科技有限公司 经培养的胰腺细胞及其培养方法和用途
WO2007009356A1 (fr) * 2005-07-15 2007-01-25 Theracells Biotechnologies Co., Ltd. Méthode pour détecter et cultiver des cellules pancréatiques et application
US7776592B2 (en) * 2005-08-31 2010-08-17 Stc.Unm Human renal stem cells
EP1971681B1 (en) * 2005-12-16 2017-08-23 DePuy Synthes Products, Inc. Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation
US8741638B2 (en) * 2005-12-19 2014-06-03 DePuy Synthes Products, LLC In vitro expansion of postpartum-derived cells in roller bottles
AU2006330409B2 (en) * 2005-12-28 2012-07-19 Ethicon, Incorporated Treatment of peripheral vascular disease using postpartum-derived cells
US9125906B2 (en) 2005-12-28 2015-09-08 DePuy Synthes Products, Inc. Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
AP2949A (en) 2006-03-07 2014-07-31 Shroff Geeta Compositions comprising human embryonic stem cellsand their derivatives, methods of use, and method s of preparation
US8741643B2 (en) 2006-04-28 2014-06-03 Lifescan, Inc. Differentiation of pluripotent stem cells to definitive endoderm lineage
US20080233087A1 (en) * 2006-10-31 2008-09-25 Shamblott Michael J Methods for identifying, isolating, and utilizing endocrine progenitor cells from adult human pancreata
EP2851422A3 (en) * 2007-05-24 2015-06-24 Apceth GmbH & Co. KG CD34neg stem cells for the treatment of gastrointestinal disorders
WO2008153568A1 (en) * 2007-06-13 2008-12-18 Lifescan, Inc. Chorionic villus derived cells
US9080145B2 (en) * 2007-07-01 2015-07-14 Lifescan Corporation Single pluripotent stem cell culture
ES2665434T3 (es) 2007-07-31 2018-04-25 Lifescan, Inc. Diferenciación de células madre pluripotentes usando células alimentadoras humanas
KR101617243B1 (ko) * 2007-07-31 2016-05-02 라이프스캔, 인코포레이티드 인간 배아 줄기 세포의 분화
BRPI0818183A2 (pt) * 2007-10-05 2019-07-16 Ethicon Inc reparo e regeneração do tecido renal usando células derivadas do tecido do cordão umbilical humano
EP2229434B1 (en) 2007-11-27 2011-09-07 Lifescan, Inc. Differentiation of human embryonic stem cells
US8236538B2 (en) * 2007-12-20 2012-08-07 Advanced Technologies And Regenerative Medicine, Llc Methods for sterilizing materials containing biologically active agents
CN102046779A (zh) 2008-02-21 2011-05-04 森托科尔奥索生物科技公司 用于细胞粘附、培养和分离的方法、表面改性培养板和组合物
US7939322B2 (en) 2008-04-24 2011-05-10 Centocor Ortho Biotech Inc. Cells expressing pluripotency markers and expressing markers characteristic of the definitive endoderm
US8623648B2 (en) 2008-04-24 2014-01-07 Janssen Biotech, Inc. Treatment of pluripotent cells
PL2310492T3 (pl) 2008-06-30 2015-12-31 Janssen Biotech Inc Różnocowanie pluripotencjalnych komórek macierzystych
US20100028307A1 (en) * 2008-07-31 2010-02-04 O'neil John J Pluripotent stem cell differentiation
AU2009308967C1 (en) 2008-10-31 2017-04-20 Janssen Biotech, Inc. Differentiation of human embryonic stem cells to the pancreatic endocrine lineage
KR102025158B1 (ko) 2008-10-31 2019-09-25 얀센 바이오테크 인코포레이티드 인간 배아 줄기 세포의 췌장 내분비 계통으로의 분화
AU2009316583B2 (en) * 2008-11-20 2016-04-21 Janssen Biotech, Inc. Methods and compositions for cell attachment and cultivation on planar substrates
MX356756B (es) 2008-11-20 2018-06-11 Centocor Ortho Biotech Inc Células madre pluripotentes en microportadores.
JP5481841B2 (ja) * 2008-11-28 2014-04-23 東ソー株式会社 サイトケラチン１９ｍＲＮＡの測定方法
BRPI0923177A2 (pt) * 2008-12-19 2020-08-25 Advanced Technologies And Regenerative Medicine, Llc usos de composições para tratar dor neuropática e espacidade, as referidas composições, e kit
CA2747794C (en) 2008-12-19 2018-10-30 Advanced Technologies And Regenerative Medicine, Llc Treatment of lung and pulmonary diseases and disorders
EP2379089B1 (en) * 2008-12-19 2019-04-17 DePuy Synthes Products, Inc. Regeneration and repair of neural tissue following injury
US10179900B2 (en) * 2008-12-19 2019-01-15 DePuy Synthes Products, Inc. Conditioned media and methods of making a conditioned media
CA2756600C (en) 2009-03-26 2019-08-20 Advanced Technologies And Regenerative Medicine, Llc Human umbilical cord tissue cells as therapy for alzheimer's disease
GB0908934D0 (en) 2009-05-26 2009-07-01 Univ The West Of Scotland Differentiation medium
EP2456862A4 (en) 2009-07-20 2013-02-27 Janssen Biotech Inc DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS
SG177416A1 (en) * 2009-07-20 2012-02-28 Janssen Biotech Inc Differentiation of human embryonic stem cells
AU2010276440B2 (en) * 2009-07-20 2014-07-03 Janssen Biotech Inc. Differentiation of human embryonic stem cells
CN102712902B (zh) * 2009-12-23 2019-01-08 詹森生物科技公司 人胚胎干细胞的分化
CN102741395B (zh) * 2009-12-23 2016-03-16 詹森生物科技公司 人胚胎干细胞的分化
RU2702198C2 (ru) 2010-03-01 2019-10-04 Янссен Байотек, Инк. Способы очистки клеток, производных от плюрипотентных стволовых клеток
RU2587634C2 (ru) 2010-05-12 2016-06-20 Янссен Байотек, Инк. Дифференцирование эмбриональных стволовых клеток человека
BR112013004614A2 (pt) 2010-08-31 2024-01-16 Janssen Biotech Inc Diferenciação de células-tronco pluripotentes
KR101851956B1 (ko) 2010-08-31 2018-04-25 얀센 바이오테크 인코포레이티드 인간 배아 줄기 세포의 분화
WO2012030539A2 (en) 2010-08-31 2012-03-08 Janssen Biotech, Inc. Differentiation of human embryonic stem cells
CN102321572A (zh) * 2011-01-29 2012-01-18 余跃红 一种纯化、识别胰腺内分泌细胞的方法
KR102203056B1 (ko) 2011-12-22 2021-01-14 얀센 바이오테크 인코포레이티드 인간 배아 줄기 세포의 단일 인슐린 호르몬 양성 세포로의 분화
ES2676556T3 (es) 2011-12-23 2018-07-20 Depuy Synthes Products Llc Detección de células derivadas de tejido del cordón umbilical humano
SG11201405052RA (en) 2012-03-07 2014-10-30 Janssen Biotech Inc Defined media for expansion and maintenance of pluripotent stem cells
CN108034633B (zh) 2012-06-08 2022-08-02 詹森生物科技公司 人胚胎干细胞向胰腺内分泌细胞的分化
EP2864473B1 (en) 2012-06-26 2019-08-21 Seraxis, Inc. Stem cells and pancreatic cells useful for the treatment of insulin-dependent diabetes mellitus
JP6057574B2 (ja) * 2012-07-11 2017-01-11 キヤノン株式会社 造血幹細胞識別用プローブ
US10370644B2 (en) 2012-12-31 2019-08-06 Janssen Biotech, Inc. Method for making human pluripotent suspension cultures and cells derived therefrom
BR112015015714A2 (pt) 2012-12-31 2017-07-11 Janssen Biotech Inc suspensão e aglomeração de células pluripotentes humanas para diferenciação em célu-las endócrinas pancreáticas
EP2938724B1 (en) 2012-12-31 2020-10-28 Janssen Biotech, Inc. Culturing of human embryonic stem cells at the air-liquid interface for differentiation into pancreatic endocrine cells
AU2013368224B2 (en) 2012-12-31 2018-09-27 Janssen Biotech, Inc. Differentiation of human embryonic stem cells into pancreatic endocrine cells using HB9 regulators
US10507220B2 (en) 2013-03-15 2019-12-17 Philadelphia Medical Scientific Center L.L.C. Cell therapy: a method and a composition for treating diabetes
EP3143127B1 (en) 2014-05-16 2021-07-14 Janssen Biotech, Inc. Use of small molecules to enhance mafa expression in pancreatic endocrine cells
RU2579997C2 (ru) * 2014-07-24 2016-04-10 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт фармакологии имени Е.Д. Гольдберга" Сибирского отделения Российской академии медицинских наук СПОСОБ ИНДУКЦИИ НАПРАВЛЕННОЙ ДИФФЕРЕНЦИРОВКИ МУЛЬТИПОТЕНТНЫХ ПРОГЕНИТОРНЫХ КЛЕТОК ПОДЖЕЛУДОЧНОЙ ЖЕЛЕЗЫ В ИНСУЛИН-ПРОДУЦИРУЮЩИЕ β-КЛЕТКИ ПРИ САХАРНОМ ДИАБЕТЕ
US11534466B2 (en) * 2016-03-09 2022-12-27 Aal Scientifics, Inc. Pancreatic stem cells and uses thereof
MA45479A (fr) 2016-04-14 2019-02-20 Janssen Biotech Inc Différenciation de cellules souches pluripotentes en cellules de l'endoderme de l'intestin moyen
US11845956B2 (en) * 2018-09-21 2023-12-19 APstem Therapeutics, Inc. Human pluripotent adult stem cells
JP2023516484A (ja) 2020-03-11 2023-04-19 ビット バイオ リミテッド 肝細胞作製方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2235509A1 (en) 1995-10-25 1997-05-01 Ammon B. Peck In vitro growth of functional islets of langerhans and in vivo uses thereof
US7622557B2 (en) * 1998-05-28 2009-11-24 St. Jude Children's Research Hospital Antibodies having binding specificity for the extracellular domain of a breast cancer resistance protein (BCRP)
US7056734B1 (en) * 1998-08-10 2006-06-06 The United States Of America As Represented By The Department Of Health And Human Services, Nih Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or exendin-4 and uses thereof
AU778929B2 (en) * 1999-12-06 2004-12-23 General Hospital Corporation, The Pancreatic stem cells and their use in transplantation
US6610535B1 (en) * 2000-02-10 2003-08-26 Es Cell International Pte Ltd. Progenitor cells and methods and uses related thereto
ES2377099T3 (es) * 2001-12-04 2012-03-22 Organogenesis Inc. Células cultivadas procedentes de islotes pancreáticos
US20030109036A1 (en) * 2001-12-06 2003-06-12 The Regents Of The University Of California Method for differentiating islet precursor cells into beta cells

Also Published As

Publication number Publication date
CN1589330A (zh) 2005-03-02
US8110399B2 (en) 2012-02-07
EP1438418B1 (en) 2010-11-24
IL161119A0 (en) 2004-08-31
AU2002331910B2 (en) 2007-10-11
CA2461861A1 (en) 2003-04-03
DE60238431D1 (de) 2011-01-05
EP1438418A4 (en) 2005-12-21
ATE489475T1 (de) 2010-12-15
US20030082155A1 (en) 2003-05-01
WO2003026584A3 (en) 2003-09-18
US20070128176A1 (en) 2007-06-07
JP2005533746A (ja) 2005-11-10
WO2003026584A2 (en) 2003-04-03
EP1438418A2 (en) 2004-07-21

Similar Documents

Publication Publication Date Title
HK1067155A1 (en) Stem cells of the islets of langerhans and their use in treating diabetes mellitus
Kanafi et al. Transplantation of islet-like cell clusters derived from human dental pulp stem cells restores normoglycemia in diabetic mice
Chang et al. Placenta-derived multipotent stem cells induced to differentiate into insulin-positive cells
US20090274663A1 (en) Materials and Methods Relating to Cell Based Therapies
US9127254B2 (en) Scaffolding for tissue regeneration or repair
Lootens et al. Keratinocytes in the treatment of severe burn injury: an update
GB2393734A (en) Cells of the cardiomyocyte lineage produced from human pluripotent stem cells
FI20085733A (fi) Menetelmiä sairauden hoitamiseksi käyttäen Sertoli-soluja ja allografteja tai ksenografteja
Gabr et al. Generation of Insulin‐Producing Cells from Human Bone Marrow‐Derived Mesenchymal Stem Cells: Comparison of Three Differentiation Protocols
CA2362593A1 (en) Pancreatic progenitor cells, methods and uses related thereto
CA2187526A1 (en) Methods of use of uncoated gel particles
WO2007081654A3 (en) Compositions and methods to enhance viability and function of islet cells
WO2003048336A3 (en) Cultured cells from pancreatic islets
EP1490480A4 (en) PRIMITIVE AND PROXIMAL HEPATIC STEM CELLS
ATE553186T1 (de) Bandscheibenreparatur und verfahren dafür
HK1125291A1 (en) Method of using guava extract and composition including guava extract
Sambathkumar et al. Pluripotent stem cell-derived pancreatic progenitors and β-like cells for type 1 diabetes treatment
Mehrabi et al. Differentiation of human skin-derived precursor cells into functional islet-like insulin-producing cell clusters
TR199903142T2 (xx) Pankreas dokusu adac��� transplantasyonu i�in CD154 blokaj tedavisi.
Zhang et al. Evaluation of islets derived from human fetal pancreatic progenitor cells in diabetes treatment
BRPI0316666B8 (pt) novo uso de sulfato de dextrano
Roche et al. Role of small bioorganic molecules in stem cell differentiation to insulin-producing cells
RU2008145053A (ru) Клеточная терапия: композиция и способ для лечения диабета
Tu et al. Comparison of fetal porcine aggregates of purified β-cells versus islet-like cell clusters as a treatment of diabetes
Tashiro et al. Microencapsulation improves viability of islets from CSK miniature swine

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180924